Cristina Lupo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Cristina Lupo has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Francesca Taraballi
Center for Musculoskeletal Regeneration, Houston Methodist Academic Institute, Houston, TX 77030, USA
5 shared publications - Laura Cipolla
Department of Biotechnology and Biosciences, University of Milano-Bicocca, 20126 Milano, Italy
3 shared publications - Laura Russo
School of Medicine and Surgery Università degli Studi Milano‐Bicocca Vedano al Lambro (MB) Italy
3 shared publications Alice Capitoli
2 shared publications- Ana Poveda
CICbioGUNE, Basque Research and Technology Alliance
1 shared publication Anna Tampieri
Institute of Science and Technology for Ceramics - National Research Council of Italy (ISTEC-CNR) , Via Granarolo, 64, Faenza, Ravenna 48018 , Italy
1 shared publication
Latest Publications
- 2 February 2017
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 28 (3) , 1-14
A nanofibrous electrospun patch to maintain human mesenchymal cell stemness
Mesenchymal stem cells (MSCs) have been extensively investigated in regenerative medicine because of their crucial role in tissue healing. For these proper
- 2 February 2017
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 28 (3) , 1-14
A nanofibrous electrospun patch to maintain human mesenchymal cell stemness
Mesenchymal stem cells (MSCs) have been extensively investigated in regenerative medicine because of their crucial role in tissue healing. For these proper
- Open Access
- 6 February 2014
- Published by The Royal Society in Interface Focus
- Vol. 4 (1) , 20130040
Carbonate hydroxyapatite functionalization: a comparative study towards (bio)molecules fixation
Different methods for the functionalization of carbonate hydroxyapatite granules with free amine groups by reaction with (3-aminopropyl)triethoxysilane (APTES) have been compared in order to improve the potential for tethering of bioactive molecules to bioceramics. The combined use of tetraethoxyorthosilicate and APTES with acid catalysis resulted in an evident increase in amine surface grafting.
- 6 February 2014
- Published by The Royal Society in Interface Focus
- Vol. 4 (1) , 20130040
Open AccessCarbonate hydroxyapatite functionalization: a comparative study towards (bio)molecules fixation
Different methods for the functionalization of carbonate hydroxyapatite granules with free amine groups by reaction with (3-aminopropyl)triethoxysilane (APTES) have been compared in order to improve the potential for tethering of bioactive molecules to bioceramics. The combined use of tetraethoxyorthosilicate and APTES with acid catalysis resulted in an evident increase in amine surface grafting.
- 1 March 2013
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 394, 590-597
Amino and carboxyl plasma functionalization of collagen films for tissue engineering applications
- 1 March 2013
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 394, 590-597
Amino and carboxyl plasma functionalization of collagen films for tissue engineering applications
- 23 August 2012
- Published by Royal Society of Chemistry (RSC) in Carbohydrate Chemistry
- p. 416-445
Smart biomaterials: the contribution of glycoscience
Examples of material functionalisation (“biodecoration”) with signalling and relevant glycidic scaffolds will be outlined. Recent research concerning the development of smart biomaterials for Tissue Engineering (TE) applications will be considered.
- 23 August 2012
- Published by Royal Society of Chemistry (RSC) in Carbohydrate Chemistry
- p. 416-445
Smart biomaterials: the contribution of glycoscience
Examples of material functionalisation (“biodecoration”) with signalling and relevant glycidic scaffolds will be outlined. Recent research concerning the development of smart biomaterials for Tissue Engineering (TE) applications will be considered.
- 1 August 2012
- Published by Bentham Science Publishers Ltd. in Current Drug Targets
- Vol. 13 (11) , 1458-1471
Recent approaches to novel antibacterials designed after LPS structure and biochemistry.
Abstract: Lipopolysaccharides (LPSs), which constitute the lipid portion of the outer leaflet of Gram-negative bacteria, are essential for growth, and are responsible for a variety of biological effects associated with Gram-negative sepsis. LPSs are amphiphilic molecules comprising three regions: lipid A, the core region, and a polysaccharide portion; the lipid A was proven to represent the toxic principle of endotoxic active lipopolysaccharides. In addition, it is known that the minimal conserved structure of LPS is the lipophylic oligoasaccharidic structure containing Kdo residues linked to the-LipA moiety. Thus, the design and development of novel antibacterial drugs can focus on different aspects, related to the biosynthesis and chemical features of LPS: 1) Inhibitors of lipid A biosynthesis 2) Inhibitors of Kdo biosynthesis. Both Kdo and Lipid A are needed for the construction of the minimum structural element Kdo2-LipidA, needed for bacterial survival. Any inhibitors acting on the biogenetic pathway of this molecule can act as antibacterial. 3) Antagonists of the interaction between endotoxins and the host receptors: LPS is recognised by the CD14 and the Toll-like receptor (TLR)- 4/MD2 complex, where Lipid A is the crucial moiety in the interaction. Any drug acting as an antagonist of this process can have antisepsis potential. Considerable efforts have been made in this direction to identify natural or synthetic molecules able to interfere with the interaction between LPS and inflammatory cells. This review will highlight recent efforts in the design and biological activity of enzyme inhibitors and antagonist acting on the 3 key aspects outlined above.
- 1 August 2012
- Published by Bentham Science Publishers Ltd. in Current Drug Targets
- Vol. 13 (11) , 1458-1471
Recent approaches to novel antibacterials designed after LPS structure and biochemistry.
Abstract: Lipopolysaccharides (LPSs), which constitute the lipid portion of the outer leaflet of Gram-negative bacteria, are essential for growth, and are responsible for a variety of biological effects associated with Gram-negative sepsis. LPSs are amphiphilic molecules comprising three regions: lipid A, the core region, and a polysaccharide portion; the lipid A was proven to represent the toxic principle of endotoxic active lipopolysaccharides. In addition, it is known that the minimal conserved structure of LPS is the lipophylic oligoasaccharidic structure containing Kdo residues linked to the-LipA moiety. Thus, the design and development of novel antibacterial drugs can focus on different aspects, related to the biosynthesis and chemical features of LPS: 1) Inhibitors of lipid A biosynthesis 2) Inhibitors of Kdo biosynthesis. Both Kdo and Lipid A are needed for the construction of the minimum structural element Kdo2-LipidA, needed for bacterial survival. Any inhibitors acting on the biogenetic pathway of this molecule can act as antibacterial. 3) Antagonists of the interaction between endotoxins and the host receptors: LPS is recognised by the CD14 and the Toll-like receptor (TLR)- 4/MD2 complex, where Lipid A is the crucial moiety in the interaction. Any drug acting as an antagonist of this process can have antisepsis potential. Considerable efforts have been made in this direction to identify natural or synthetic molecules able to interfere with the interaction between LPS and inflammatory cells. This review will highlight recent efforts in the design and biological activity of enzyme inhibitors and antagonist acting on the 3 key aspects outlined above.